Feature Image

The Street: How the U.S. Government Makes Money on Cannabis

Posted on

Kananlife Sciences was mentioned in an article by The Street about how the government cashes in on Cannabis.

In June of 2013, the NIH granted the exclusive license to phyto-medical company KannaLife Sciences. Dean Petkanus CEO of KannaLife said it was very difficult to get the exclusive license to the patent. The company has the license for only one disease, Hepatic Encephalopathy, that is associated with liver disorders. It occurs in people with cirrhosis from alcoholism or hepatitis C and B as a couple of examples.

View full size PDF in new window

View Original Article